StonvexLoading…
StonvexStonvexStonvexCore line items from RSKD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $344.64M | $327.52M | $297.61M | $261.25M |
Operating Income | $-34.03M | $-47.85M | $-76.85M | $-109.35M |
Net Income | $-27.57M | $-34.92M | $-59.03M | $-104.70M |
EPS (Diluted) | Not available | Not available | Not available | $0.62 |
Total Assets | $410.57M | $495.86M | $601.93M | $606.98M |
Total Liabilities | $115.81M | $113.56M | $110.21M | $112.55M |
Cash & Equivalents | $162.15M | $371.06M | $440.84M | $188.67M |
Free Cash Flow OCF − CapEx | $33.07M | $39.06M | $5.92M | $-32.38M |
Shares Outstanding | 157.46M | 170.91M | 176.77M | 167.67M |